Cleveland BioLabs, Inc. (Nasdaq:CBLI) is a clinical-stage biotechnology company with a focus on oncology and orphan drug development.
Since our inception in 2003, we have pursued the research, development and commercialization of proprietary products that have the potential to treat cancer, prevent and treat acute radiation syndrome and counteract the toxic effects of radio and chemotherapies for oncology patients.
Presently, we have nine product candidates in our pipeline that are being developed directly by us and our majority-owned subsidiaries, Incuron, LLC and Panacela Labs, Inc.
Company Details
- Employees
- 23
- Founded
- 2003
- Address
- 73 High St, Buffalo,ny 14203,united States
- Phone
- 7168496820
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cbiolabs.com
- HQ
- Buffalo, NY
Cleveland Biolabs Questions
Cleveland Biolabs's helpline number is 7168496820
Cleveland Biolabs's website is cbiolabs.com
Cleveland Biolabs's LinkedIn profile is https://www.linkedin.com/company/cleveland-biolabs
Cleveland Biolabs has
23 employees.
View email and phone details for 23
employees at Cleveland Biolabs.
Cleveland Biolabs's industry is
Biotechnology Research
Cleveland Biolabs's top competitors are
Everon Biosciences,
Pop Biotechnologies,
Ufc Biotechnology,
Tartis Inc,
Therapyx Inc,
Zeptometrix,
Pharmathene Us Corp,
Reassure,
Roswell Park Comprehensive Cancer Center,
22nd Century Group, Inc..
Cleveland Biolabs's categories are Biotechnology Research
Cleveland Biolabs's founding year is 2003
